Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CNAB OTCMKTS:LBUY OTCMKTS:PKPH NASDAQ:XXII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNABUnited Cannabis$0.00$0.02▼$0.78$1.55MN/A730,433 shs7.53 million shsLBUYLeafbuyer Technologies$0.02+3.3%$0.02$0.00▼$0.15$2.13M2.7844,430 shs3,800 shsPKPHPeak Pharmaceuticals$1.00+17.6%$1.41$0.52▼$9.12$392K0.549,053 shs1,422 shsXXII22nd Century Group$3.04-15.1%$12.77$2.88▼$2,430.59$1.81M1.78152,798 shs785,313 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNABUnited Cannabis0.00%0.00%0.00%0.00%0.00%LBUYLeafbuyer Technologies+0.47%+6.50%+1.43%-14.80%+4,160.00%PKPHPeak Pharmaceuticals0.00%-8.11%-42.95%-75.71%-73.44%XXII22nd Century Group-8.44%-30.35%-58.94%-79.44%-99.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNABUnited CannabisN/AN/AN/AN/AN/AN/AN/AN/ALBUYLeafbuyer TechnologiesN/AN/AN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AXXII22nd Century Group0.3161 of 5 stars0.03.00.00.01.10.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNABUnited Cannabis 0.00N/AN/AN/ALBUYLeafbuyer Technologies 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/AXXII22nd Century Group 0.00N/AN/AN/ALatest PKPH, LBUY, XXII, and CNAB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/12/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)6/27/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)6/11/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)5/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)5/10/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)4/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNABUnited CannabisN/AN/AN/AN/AN/AN/ALBUYLeafbuyer Technologies$5.60M0.39N/AN/A($0.02) per share-1.10PKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AXXII22nd Century Group$24.38M0.06N/AN/A$53.71 per share0.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNABUnited CannabisN/AN/A0.00N/AN/AN/AN/AN/AN/ALBUYLeafbuyer Technologies-$710KN/A0.00∞N/A3.68%-15.55%25.98%N/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/AXXII22nd Century Group-$15.16M-$2,986.49N/A∞N/A-57.62%-524.68%-57.04%8/12/2025 (Estimated)Latest PKPH, LBUY, XXII, and CNAB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025XXII22nd Century Group-$0.27N/AN/AN/AN/AN/A5/13/2025Q1 2025XXII22nd Century Group-$25.30-$43.47-$18.17-$2.50$4.70 million$5.96 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNABUnited CannabisN/AN/AN/AN/AN/ALBUYLeafbuyer TechnologiesN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AXXII22nd Century GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCNABUnited CannabisN/AN/AN/ALBUYLeafbuyer TechnologiesN/A0.450.45PKPHPeak PharmaceuticalsN/A0.150.15XXII22nd Century GroupN/A0.680.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNABUnited CannabisN/ALBUYLeafbuyer Technologies11.03%PKPHPeak PharmaceuticalsN/AXXII22nd Century Group18.06%Insider OwnershipCompanyInsider OwnershipCNABUnited CannabisN/ALBUYLeafbuyer Technologies24.44%PKPHPeak Pharmaceuticals18.40%XXII22nd Century Group0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNABUnited Cannabis6593.73 millionN/ANot OptionableLBUYLeafbuyer Technologies20100.07 million75.61 millionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionableXXII22nd Century Group80510,000506,000OptionablePKPH, LBUY, XXII, and CNAB HeadlinesRecent News About These Companies22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional ProductsJuly 17, 2025 | globenewswire.comVLN Commercial Launches Confirm Viability of the FDA’s Proposed Reduced Nicotine MandateJuly 17, 2025 | finance.yahoo.com22nd Century Group stock soars after expanding VLN cigarette partnershipsJuly 17, 2025 | investing.com22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine PushJuly 17, 2025 | benzinga.comVLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine MandateJuly 16, 2025 | globenewswire.com22nd Century Group's (XXII) "Sell (E)" Rating Reiterated at Weiss RatingsJuly 15, 2025 | americanbankingnews.com22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke LessJuly 10, 2025 | globenewswire.com22nd Century Group, Inc. (XXII) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comXXII - 22nd Century Group Inc Price vs Fair Value - MorningstarJune 26, 2025 | morningstar.comM22nd Century Group developing 100mm very low nicotine cigaretteJune 26, 2025 | msn.com22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine ConsumptionJune 26, 2025 | globenewswire.com22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store ChainJune 24, 2025 | finance.yahoo.com22nd Century announces updates to Pinnacle manufacturing, marketing agreementJune 24, 2025 | msn.com22nd Century limits fiscal 2024 executive compensation, proposes another reverse stock splitMay 27, 2025 | journalnow.comJEmerging Growth Research Releases Q1 2025 Update Report on 22nd Century GroupMay 21, 2025 | newsfilecorp.comN22nd Century to Present at the Emerging Growth Conference on May 21, 2025May 19, 2025 | globenewswire.com22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.com22nd Century: Q1 Earnings SnapshotMay 14, 2025 | wtop.comW22nd Century reports lower quarterly loss, still no net revenue from very-low-nicotine cigarettesMay 14, 2025 | journalnow.comJ22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...May 14, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, LBUY, XXII, and CNAB Company DescriptionsUnited Cannabis OTCMKTS:CNABUnited Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Golden, Colorado.Leafbuyer Technologies OTCMKTS:LBUY$0.02 +0.00 (+3.29%) As of 11:53 AM EasternLeafbuyer Technologies, Inc., through its subsidiary, LB Media Group, LLC, provides online resources for cannabis deals and specials in the United States. The company was founded in 2012 and is headquartered in Greenwood Village, Colorado.Peak Pharmaceuticals OTCMKTS:PKPH$1.00 +0.15 (+17.65%) As of 07/21/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.22nd Century Group NASDAQ:XXII$3.04 -0.54 (-15.08%) Closing price 04:00 PM EasternExtended Trading$3.13 +0.09 (+2.99%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Block Levels Up: What S&P 500 Inclusion Means for Investors Steel Dynamics Stock Steady on Long-Term Prospects Amazon Stock Rally Hits New Highs: Buy Into Earnings? A Bullish Storm Is Brewing for High-Yield Verizon’s Share Price Forget the Hype—TSMC Is the AI Stock That Actually Delivers Rigetti Soars 30% on Latest Quantum Leap: What It Means Long-Term Domino’s Delivers Another Discounted Entry for Income Investors Palantir Bulls and Bears Set for an August Showdown Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
